Decibel Therapeutics Inc. (DBTX)
NASDAQ: DBTX
· Real-Time Price · USD
4.91
-0.04 (-0.81%)
At close: Sep 22, 2023, 10:00 PM
Decibel Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -66M | -64.06M | -63.96M | -60.37M | -58.72M | -53.35M | -50.23M | -50.34M | -42.72M | -38.85M |
Interest Income | 2.89M | 2.01M | 1.19M | 584K | 243K | 223K | 193K | 93K | 62K | 9K |
Pretax Income | -63.11M | -62.05M | -62.77M | -59.78M | -58.47M | -53.11M | -50.03M | -50.07M | -42.52M | -38.67M |
Net Income | -63.39M | -62.29M | -63.01M | -59.97M | -60.36M | -54.97M | -51.82M | -51.8M | -42.52M | -38.67M |
Selling & General & Admin | 23.61M | 23.26M | 23.63M | 23.66M | 23.02M | 22.05M | 20.38M | 20.57M | 17.29M | 14.95M |
Research & Development | 42.38M | 40.8M | 40.33M | 36.72M | 35.71M | 31.29M | 29.85M | 29.76M | 25.43M | 23.91M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25K | n/a |
Operating Expenses | 66M | 64.06M | 63.96M | 60.37M | 58.72M | 53.35M | 50.23M | 50.34M | 42.72M | 38.85M |
Interest Expense | 1.03M | 1.13M | 1.13M | 469K | 95K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 66M | 64.06M | 63.96M | 60.37M | 58.72M | 53.35M | 50.23M | 50.34M | 42.72M | 38.85M |
Income Tax Expense | 283K | 241K | 240K | 193K | 1.9M | 1.86M | 1.8M | 1.73M | -2K | -24K |
Shares Outstanding (Basic) | 25.02M | 24.99M | 24.96M | 24.96M | 24.96M | 24.96M | 24.95M | 24.87M | 24.87M | 23.99M |
Shares Outstanding (Diluted) | 25.02M | 24.99M | 24.96M | 24.96M | 24.96M | 24.96M | 24.95M | 24.87M | 24.87M | 23.99M |
EPS (Basic) | -2.54 | -2.49 | -2.52 | -2.4 | -2.42 | -2.21 | -2.1 | -2.14 | -2.45 | -3.04 |
EPS (Diluted) | -2.54 | -2.49 | -2.52 | -2.4 | -2.42 | -2.21 | -2.1 | -2.14 | -2.45 | -3.04 |
EBITDA | -64.6M | -62.62M | -62.49M | -58.98M | -57.35M | -51.99M | -48.82M | -49.23M | -41.57M | -37.62M |
EBIT | -63.81M | -61.68M | -61.7M | -59.44M | -58.53M | -53.35M | -50.23M | -37.33M | -29.72M | -25.84M |
Depreciation & Amortization | 1.4M | 1.44M | 1.46M | 1.4M | 1.38M | 1.35M | 1.41M | 1.45M | 1.5M | 1.58M |